Beta blockers have been shown to prolong survival in chronic heart failure. It is currently a ... comparative studies have been performed with metoprolol, a β 1-selective "second-generation ...

Maack et al. [70] recently reported on switching between β blockers (metoprolol and carvedilol) in 68 patients treated with either agent for 1 year who had improved in terms of LVEF and NYHA class.

Metoprolol is a beta-blocker approved by the Food and Drug Administration (FDA) to treat several cardiovascular conditions, including high blood pressure, heart failure, and angina (chest pain).

Metoprolol is a commonly prescribed beta-blocker medication used to treat high blood pressure, angina (chest pain), heart ...

Specifically, COPERNICUS (led in the UK by Professor Coats at Imperial) showed general efficacy of beta-blockers in heart failure; COMET (designed and led by Professor Poole-Wilson at Imperial) showed ...

However, among the subgroup of patients who were not taking a β-blocker such as metoprolol, use of an α-antagonist increased the likelihood of admission for heart failure by a factor of almost two.

They're prescribed to people with some irregular heart rhythms, heat attacks, heart failure ... the eight most common generic beta blocker drugs are metoprolol, carvedilol, atenolol, propranolol ...

Lipid solubility: Beta-blockers that are lipid soluble, such as propranolol or metoprolol ... hospitalized for acute systolic congestive heart failure prior to hospital discharge.

Beta blockers, also known as beta-adrenergic blocking agents, are a class of medications commonly used to treat cardiovascular conditions, including angina, aortic dissection, heart failure ...

The classification of drugs have been around since 1964 after Sir James Black discovered how they can assist people with heart disease.